Literature DB >> 28575493

miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Xin Wang1,2, Borja L Holgado1, Vijay Ramaswamy1,3, Stephen Mack1, Kory Zayne1, Marc Remke4, Xiaochong Wu1, Livia Garzia1, Craig Daniels1, Anna M Kenney1,5,6, Michael D Taylor1,2,7.   

Abstract

microRNAs (miRNAs) have wide-ranging effects on large-scale gene regulation. As such, they play a vital role in dictating normal development, and their aberrant expression has been implicated in cancer. There has been a large body of research on the role of miRNAs in medulloblastoma, the most common malignant brain tumor of childhood. The identification of the 4 molecular subgroups with distinct biological, genetic, and transcriptional features has revolutionized the field of medulloblastoma research over the past 5 years. Despite this, the growing body of research on miRNAs in medulloblastoma has largely focused on the clinical entity of a single disease rather than the molecular subgroups. This review begins by highlighting the role of miRNAs in development and progresses to explore their myriad of implications in cancer. Medulloblastoma is characterized by increased proliferation, inhibition of apoptosis, and maintenance of stemness programs-features that are inadvertently regulated by altered expression patterns in miRNAs. This review aims to contextualize the large body of work on miRNAs within the framework of medulloblastoma subgroups. The goal of this review is to stimulate new areas of research, including potential therapeutics, within a rapidly growing field.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28575493      PMCID: PMC5817951          DOI: 10.1093/neuonc/nox106

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  96 in total

Review 1.  Bmi1, stem cells, and senescence regulation.

Authors:  In-Kyung Park; Sean J Morrison; Michael F Clarke
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 3.  Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.

Authors:  Xin Wang; Vijay Ramaswamy; Marc Remke; Stephen C Mack; Adrian M Dubuc; Paul A Northcott; Michael D Taylor
Journal:  Neurosurgery       Date:  2013-08       Impact factor: 4.654

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 5.  MicroRNA control of signal transduction.

Authors:  Masafumi Inui; Graziano Martello; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03-10       Impact factor: 94.444

6.  MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3).

Authors:  Kay Ka-Wai Li; Jesse Chung-Sean Pang; Kin-Mang Lau; Liangfu Zhou; Ying Mao; Yin Wang; Wai-Sang Poon; Ho-Keung Ng
Journal:  Brain Pathol       Date:  2013-01-09       Impact factor: 6.508

7.  MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis.

Authors:  Boyan Bonev; Angela Pisco; Nancy Papalopulu
Journal:  Dev Cell       Date:  2011-01-18       Impact factor: 12.270

8.  MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

Authors:  Pasqualino de Antonellis; Chiara Medaglia; Emilio Cusanelli; Immacolata Andolfo; Lucia Liguori; Gennaro De Vita; Marianeve Carotenuto; Annamaria Bello; Fabio Formiggini; Aldo Galeone; Giuseppe De Rosa; Antonella Virgilio; Immacolata Scognamiglio; Manuela Sciro; Giuseppe Basso; Johannes H Schulte; Giuseppe Cinalli; Achille Iolascon; Massimo Zollo
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

9.  MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.

Authors:  Yucui Jin; Anwen Xiong; Ziyu Zhang; Sanen Li; Huijie Huang; Ting-ting Yu; Xiumei Cao; Steven Y Cheng
Journal:  Oncotarget       Date:  2014-07-15

10.  FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.

Authors:  Aldwin Suryo Rahmanto; Vasil Savov; Andrä Brunner; Sara Bolin; Holger Weishaupt; Alena Malyukova; Gabriela Rosén; Matko Čančer; Sonja Hutter; Anders Sundström; Daisuke Kawauchi; David Tw Jones; Charles Spruck; Michael D Taylor; Yoon-Jae Cho; Stefan M Pfister; Marcel Kool; Andrey Korshunov; Fredrik J Swartling; Olle Sangfelt
Journal:  EMBO J       Date:  2016-09-13       Impact factor: 11.598

View more
  9 in total

Review 1.  Medulloblastoma epigenetics and the path to clinical innovation.

Authors:  Amanda R Haltom; Stephanie A Toll; Donghang Cheng; Shinji Maegawa; Vidya Gopalakrishnan; Soumen Khatua
Journal:  J Neurooncol       Date:  2020-08-20       Impact factor: 4.130

2.  Validation of microRNA Target Genes Using Luciferase Reporter assay and Western Blot Analysis.

Authors:  Pooja Panwalkar; Atul Khire; Neelam Shirsat
Journal:  Methods Mol Biol       Date:  2022

3.  Pediatric brain tumor cell lines exhibit miRNA-depleted, Y RNA-enriched extracellular vesicles.

Authors:  Setty M Magaña; Timothy E Peterson; Jared E Evans; Paul A Decker; Vernadette Simon; Jeanette E Eckel-Passow; David J Daniels; Ian F Parney
Journal:  J Neurooncol       Date:  2022-01-05       Impact factor: 4.130

4.  Electrochemical biosensing of circulating microRNA-21 in cerebrospinal fluid of medulloblastoma patients through target-induced redox signal amplification.

Authors:  Chen Wang; Yujie Liu; Ruoping Chen; Xiaoqiang Wang; Yunkun Wang; Jia Wei; Kun Zhang; Chenran Zhang
Journal:  Mikrochim Acta       Date:  2022-02-14       Impact factor: 6.408

Review 5.  Medulloblastomics revisited: biological and clinical insights from thousands of patients.

Authors:  Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott
Journal:  Nat Rev Cancer       Date:  2019-12-09       Impact factor: 69.800

6.  Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.

Authors:  Harish Shrikrishna Bharambe; Raikamal Paul; Pooja Panwalkar; Rakesh Jalali; Epari Sridhar; Tejpal Gupta; Aliasgar Moiyadi; Prakash Shetty; Sadaf Kazi; Akash Deogharkar; Shalaka Masurkar; Kedar Yogi; Ratika Kunder; Nikhil Gadewal; Atul Goel; Naina Goel; Girish Chinnaswamy; Vijay Ramaswamy; Neelam Vishwanath Shirsat
Journal:  Acta Neuropathol Commun       Date:  2019-04-03       Impact factor: 7.801

Review 7.  Liquid Biomarkers for Pediatric Brain Tumors: Biological Features, Advantages and Perspectives.

Authors:  Sibylle Madlener; Johannes Gojo
Journal:  J Pers Med       Date:  2020-11-27

Review 8.  miRNA therapeutics in precision oncology: a natural premium to nurture.

Authors:  Chakresh Kumar Jain; Poornima Srivastava; Amit Kumar Pandey; Nisha Singh; R Suresh Kumar
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

Review 9.  Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups.

Authors:  Emilia Bevacqua; Jasmin Farshchi; Maria Victoria Niklison-Chirou; Paola Tucci
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.